• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Longtop Financial Technologies Limited ADR

Longtop Financial Technologies Limited ADR

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Bristol-Myers Squibb Announces Phase 1 Results from First Trial Combining Immune Checkpoint Inhibitors, Investigational Agent Nivolumab and Yervoy® (ipilimumab), in Patients with Advanced Melanoma

    Bristol-Myers Squibb Announces Phase 1 Results from First Trial Combining Immune Checkpoint Inhibitors, Investigational Agent Nivolumab and Yervoy® (ipilimumab), in Patients with Advanced Melanoma

  2. A Closer Look at a Trio of Cellar-Dwellers

    Fairholme Fund isn't the only one struggling in 2011.

  3. Fidelity and Putnam Among Fund Families Duped by Longtop

    Longtop's great growth seduced some of the biggest fund names.

Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.